Volume 373 · Number 9671 · April 11–17, 2009
The Lancet—London
1253 Zoledronic acid and risedronate in the prevention and 1224 Care for vulnerable migrants in the UK treatment of glucocorticoid-induced osteoporosis double-dummy, randomised controlled trial The Lancet—New York
1225 Glucocorticoid-induced osteoporosis: hope on the 1264 Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, 1226 Wound healing: from embryos to adults and back 1275 Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and 1228 Interventional management of resistant hypertension 1230 Gender inequality and fire-related deaths in India 1282 Fire-related deaths in India in 2001: a retrospective 1231 Serial offending: evaluation of drugs courts 1233 The HRT controversy: observational studies and RCTs 1289 Arrhythmogenic right ventricular cardiomyopathy Deputy Editor
Senior Executive Editor
1235 Sirolimus to replace calcineurin inhibitors? Too early Executive Editors
World Report
Case Report
1237 The USA shifts away from the “war on drugs” Managing Editor
Stephanie Clark
Web Editors
Senior Editors
Jane Godsland
Seema Kang
1243 Hongjie Yu: monitoring avian influenza in China 1244 Vulnerability and ethics: considering our Cartesian Conference Editor
North American Senior Editor
Maja Zecevic (New York)
Senior Assistant Editors
Hannah Cumber
Assistant Editors
Tamara Barrett
J S Earle; G Tamburlini, A Cattaneo; D Stuckler and others Farhat Yaqub
Editorial Researcher
1248 Are new drugs for schizophrenia better than old ones? P Gøtzsche; I Anghelescu, M Dettling; S Jauhar and others; S Leucht and others PR and Press Officer
Peer reviewed and fast-tracked to publication in 4 weeks B Mathews, H Payne; R Gilbert and others Editorial Assistant
1251 The UK’s NHS and pharma: need for more clinical Web Content Coordinator
See www.thelancet.com for WebExtra content 1252 Inequalities in the American health-care system International Advisory Board
Information for Authors
1252 Department of Error

Source: http://deutsche.nature.wissenschaft-online.de/sixcms/media.php/254/contents1104.pdf

Microsoft word - eval brief - meds - mar08.doc

EVALUATION BRIEF Medication Use Among Children and Youth Entering the Albany County System of Care LuAnn L. McCormick, PhD, MSW and Kenneth B. Robin, PsyD Center for Human Services Research, University at Albany, State University of New York Introduction The use of medication to treat children’s mental health disorders has increased over the past several decades. There is debate i

Annex i

NAME OF THE MEDICINAL PRODUCT DaTSCAN 74 MBq/ml solution for injection QUALITATIVE AND QUANTITATIVE COMPOSITION Ioflupane (123I) 74 MBq/ml at reference time (0.07-0.13 μg/ml of ioflupane). 2.5 ml vials contain 185 MBq and 5 ml vials contain 370 MBq ioflupane (123I) (specific activity range 2.5-4.5 x 1014 Bq/mmol) at reference time. This medicinal product contains 5% volume ethanol. Fo

Copyright © 2010-2019 Pdf Physician Treatment